Overexpression of the tissue inhibitor of metalloproteinase-3 during Xenopus embryogenesis affects head and axial tissue formation

Cell Research

Volumn 14, Issue 5, 2004, Pages 389-399

  Pickard, Bryce ^a   Damjanovski, Sashko ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Neurulation; TIMP 3; Transgenesis; Xenopus

Indexed keywords

XENOPUS LAEVIS;

LITHIUM CHLORIDE; RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BIOSYNTHESIS; COMPARATIVE STUDY; CONGENITAL MALFORMATION; GENE EXPRESSION REGULATION; GENETICS; HEAD; HUMAN; IN SITU HYBRIDIZATION; MOLECULAR GENETICS; MORPHOGENESIS; MULTIPLE MALFORMATION SYNDROME; PHYLOGENY; PRENATAL DEVELOPMENT; RADIATION EXPOSURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; ULTRAVIOLET RADIATION; XENOPUS LAEVIS;

ABNORMALITIES, MULTIPLE; AMINO ACID SEQUENCE; ANIMALS; BODY PATTERNING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEAD; HUMANS; IN SITU HYBRIDIZATION; LITHIUM CHLORIDE; MOLECULAR SEQUENCE DATA; PHYLOGENY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SEQUENCE HOMOLOGY, AMINO ACID; TISSUE INHIBITOR OF METALLOPROTEINASE-3; ULTRAVIOLET RAYS; XENOPUS LAEVIS;

EID: 16644394106     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cr.7290239     Document Type: Article

References (53)

1. Felbor U, Suvanto EA, Forsius HR, Eriksson AW, Weber BH. Autosomal recessive Sorsby fundus dystrophy revisited: molecular evidence for dominant inheritance. Am. J. Hum. Genet. 1997; 60:57-62.
2. Massova I, Kotra LP, Fridman R, Mobashery S. Matrix metalloproteinases: structures, evolution, and diversification. FASEB J 1998; 12:1075-95.
3. Yang M, Kurkinen M. Cloning and developmental regulation of tissue inhibitor of metalloproteinase-3 (TIMP3) in Xenopus laevis early embryos. Gene 1998; 211:95-100.
4. Nagase H, Woessner JF. Matrix Metalloproteinases. J Biol Chem 1999; 274:21491-94.
5. Sternlicht MD, Lochter A, Sympson CJ, et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 1999; 98:137-146.
6. Rudolph-Owen LA, Hulboy DL, Wilson CL, Mudgett J, Matrisian LM. Coordinate expression of matrix metalloproteinase family members in the uterus of normal, matrilysin-deficient, and stromely sin-1-deficient mice. Endocrinology 1997; 138:4902-11.
7. Lijnen HR, Van Hoef B, Vanlinthout I, et al. Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivation. Arterioscler Thromb Vasc Biol 1999; 19:2863-70.
8. Coussens LM, Shapiro SD, Soloway PD, Werb Z. Models for gain-of-function and loss-of-function of MMPs. Transgenic and gene targeted mice. Methods Mol Biol 2001; 151:149-79.
9. Damjanovski S, Amano T, Li Q, Pei DQ, Shi YB. Overexpression of matrix metalloproteinases leads to lethality in transgenic Xenopus laevis: Implications for tissue-dependent functions of matrix metalloproteinases during late embryonic development. Dev Dyn 2001; 221:37-47.
10. Hernandez-Barrantes S, Toth M, Bernardo MM, et al. Binding of active (57 kD) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J. Biol. Chem. 2000; 275:12080-9.
11. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behaviour. Annu. Rev. Dev. Biol. 2000; 17:463-516.
12. Leco KJ, Waterhouse P, Sanchez OH, et al. Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest 2001; 108: 817-29.
13. Creemers EE, Davis JN, Parkhurst AM, et al. Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice. Am J Physiol Heart Circ Physiol 2003; 284(1):H364-71.
14. Boucaut JC, Darribere T, Li SD, et al. Evidence for the role of fibronectin in amphibian gastrulation. J Embryol Exp Morphol 1985; 89:211-27.
15. Gross J, Lapiere CM. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci USA 1962; 48:1014-22.
16. Damjanovski S, Ishizuya-Oka A, Shi YB. Spatial and temporal expression of collagenases-3, -4, and stromelysin-3 implicates distinct functions in apoptosis and tissue remodeling during frog metamorphosis. Cell Res 1999; 9:91-110.
17. Pavloff N, Staskus PW, Kishnani MS, Hawkes SP. A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family. J Biol Chem 1992; 267:17321-26.
18. Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 1994; 269:9352-60.
19. Wick M, Burger C, Brusselbach S, Lucibello FC, Muller R. A novel member of human tissue inhibitor of metalloproteinases (TIMP) gene family is regulated during G1 progression, mitogenic stimulation, differentiation, and senescence. J Biol Chem 1994; 269:18953-60.
20. Su S, Dehnade F, Zafarullah M. Regulation of tissue inhibitor of metalloproteinases-3 gene expression by transforming growth factor-b and dexamethasone in bovine and human articular chondrocytes. DNA Cell Biol 1996; 15:1039-48.
21. Wu I, Moses MA. Cloning and expression of the cDNA encoding rat tissue inhibitor of metalloproteinase 3 (TIMP-3). Gene 1996; 168:243-6.
22. Pohar N, GodenschwegeTA, Buchner E. Invertebrate tissue inhibitor of metalloproteinase: structure and nested gene organization within the synapsin locus is conserved from Drosophila to human. Genomics 1999; 57:293-6.
23. Silbiger SM, JacobsenVL, CupplesRL, Koski RA. Cloning of cDNAs encoding human TIMP-3, a novel member of the tissue inhibitor of metalloproteinase family. Gene 1994; 141: 293-297.
24. Yu W-H, Yu SC, Meng Q, Brew K, Woessner JF. TIMP-3 binds to sulphated glycosaminoglycans of the extracellular matrix. J Biol Chem 2000; 275:31226-32.
25. Wu M, Gerhart J. Raising Xenopus in the laboratory. Methods Cell Biol 1991; 36: 3-18.
26. Nieuwkoop PD, Faber J. Normal table of Xenopus laevis: A systematic chronological survey of the development of the fertilized egg until the end of metamorphosis. Amsterdam : North Holland Publication, 1956.
27. Kao KR, Elinson RP. The entire mesodermal mantle behaves as Spemann's organizer in dorsoanterior enhanced Xenopus laevis embryos. Dev Biol 1998; 127:64-77.
28. rd ed., Cold Spring Harbor New York : Cold Spring Harbor Laboratory Press, 2000.
29. Kroll KL, Amaya E. Transgenic Xenopus embryos from sperm nuclear transplantations reveal FGF signaling requirements during gastrulation. Development 1996; 122:3173-83.
30. Huang H, Marsh-Armstrong N, Brown DD. Metamorphosis is inhibited in transgenic Xenopus laevis tadpoles that overexpress type III deiodinase. Proc Natl Acad Sci USA 1999; 96:962-7.
31. Harland RM. In situ hybridization: An improved whole mount method for Xenopus embryos. Meth Cell Biol 1991; 36:685-95.
32. McGuffin LJ, Bryson K, Jones DT. The PSIPRED protein structure prediction server. Bioinformatics. 2000; 16:404-5.
33. Higgins D, Thompson J, Gibson T, et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22:4673-80.
34. Kim JT, Kim MS, Bae MK, et al. Cloning and characterization of tissue inhibitor of metalloproteinase-3 (TIMP-3) from shark, Scyliorhinus torazame. Biochim. Biophys. Acta 2001; 1517:311-5
35. Sasai Y, Lu B, Steinbeisser H, et al. Xenopus chordin: a novel dorsalizing factor activated by organizer-specific homeobox genes. Cell 1994; 79:779-90
36. Giudice G. Conserved cellular and molecular mechanisms in development. Cell Biol Int 2001; 25:1081-90.
37. Hamilton L. The formation of somites in Xenopus. J Embryol Exp Morphol 1969; 2:253-64.
38. Brannon M, Kimelman D. Activation of Siamois by the Wnt pathway. Dev Biol 1996; 180:344-7.
39. Damjanovski S, Puzianowska-Kuznicka M, Ishuzuya-Oka A, Shi YB. Differential regulation of three thyroid hormone-responsive matrix metalloproteinase genes implicates distinct functions during frog embryogenesis. FASEB J 2000; 3:503-10.
40. Bieker JJ, Yazdani-Buicky M. Distribution of type II collagen mRNA in Xenopus embryos visualized by whole-mount in situ hybridization. J Histochem Cytochem 1992; 40: 1117-20.
41. Saha MS, Spann CL, Grainger RM. Embryonic lens induction: more than meets the optic vesicle. Cell Differ Dev 1989; 28:153-71.
42. Grainger RM. Embryonic lens induction: Shedding light on vertebrate tissue determination. Trends Genet 1992; 8:349-55.
43. Borchers A, Epperlein HH, Wedlich D. An assay system to study migratory behavior of cranial neural crest cells in Xenopus. Dev Genes Evol 2000; 210:217-22.
44. Vize PD, Melton DA. Analysis of gene function in developing Xenopus embryos. Meth Cell Biol 1991; 36:367-87.
45. Lambert E, Dassé E, Haye B, Petitfrère E. TIMPs as multifacial proteins. Crit Rev Oncol Hematol 2004; 49:187-98.
46. Balak K, Jacobson M, Sunshine J, Rutishauser U. Neural cell adhesion molecule expression in Xenopus embryos. Dev Biol 1987; 119:540-50.
47. Kuhl M, Wedlich D. Xenopus cadherins: Sorting out types and functions in embryogenesis. Dev Dyn 1996; 207:121-34.
48. Detrick RJ, Dickey D, Kintner CR. The effects of N-cadherin misexpression on morphogenesis in Xenopus embryos. Neuron 1990; 4:493-506.
49. Fujimori T, Miyatani S, Takeichi M. Ectopic expression of N-cadherin perturbs histogenesis in Xenopus embryos. Development 1990; 110:97-104.
50. Poole TJ, Thiery JP. In: Slavkin HC Eds. Progressing Clinical and Biological Research. Vol 217. Alan R. Liss, New York 1986: 235-8.
51. Penis R, Bronner-Fraser M. Recent advances in defining the role of the extracellular matrix in neural crest development. Commun Dev Neurobiol 1989; 1:61-83.
52. Wallingford JB, Harland RM. Neural tube closure requires Dishevelled-dependent convergent extension of the midline. Development 2002; 129: 5815-25.
53. Baker AH, Zaltsman AB, George SJ, Newby AC. Divergent effects of tissue inhibitor of metalloproteinase-1,-2, or-3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP3 promotes apoptosis. J. Clin. Invest. 1988; 101:1478-87.